Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Reducing inflammation in COPD: the evidence builds.

Literature DB >> 17965073

Reducing inflammation in COPD: the evidence builds.

Neil Barnes.

Abstract

Entities: Disease

Mesh：

Year: 2007 PMID： 17965073 PMCID： PMC2117134 DOI： 10.1136/thx.2007.082677

Source DB: PubMed Journal: Thorax ISSN： 0040-6376 Impact factor: 9.139

× No keyword cloud information.

16 in total

1. Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils.

Authors: D Stănescu; A Sanna; C Veriter; S Kostianev; P G Calcagni; L M Fabbri; P Maestrelli
Journal: Thorax Date: 1996-03 Impact factor: 9.139

Review 2. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary.

Authors: R A Pauwels; A S Buist; P Ma; C R Jenkins; S S Hurd
Journal: Respir Care Date: 2001-08 Impact factor: 2.258

3. Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease.

Authors: Donald A Mahler; Patrick Wire; Donald Horstman; Chai-Ni Chang; Julie Yates; Tracy Fischer; Tushar Shah
Journal: Am J Respir Crit Care Med Date: 2002-10-15 Impact factor: 21.405

4. Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease.

Authors: W Szafranski; A Cukier; A Ramirez; G Menga; R Sansores; S Nahabedian; S Peterson; H Olsson
Journal: Eur Respir J Date: 2003-01 Impact factor: 16.671

5. Effects of fluticasone propionate on inflammatory cells in COPD: an ultrastructural examination of endobronchial biopsy tissue.

Authors: M J Gizycki; K L Hattotuwa; N Barnes; P K Jeffery
Journal: Thorax Date: 2002-09 Impact factor: 9.139

6. Effects of fluticasone propionate in COPD patients with bronchial hyperresponsiveness.

Authors: G T Verhoeven; J P J J Hegmans; P G H Mulder; J M Bogaard; H C Hoogsteden; J-B Prins
Journal: Thorax Date: 2002-08 Impact factor: 9.139

7. The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study.

Authors: Keith L Hattotuwa; Mariusz J Gizycki; Tareq W Ansari; Peter K Jeffery; Neil C Barnes
Journal: Am J Respir Crit Care Med Date: 2002-06-15 Impact factor: 21.405

8. Antiinflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary disease.

Authors: Elizabeth Gamble; Diana C Grootendorst; Christopher E Brightling; Susannah Troy; Yusheng Qiu; Jie Zhu; Debbie Parker; Dean Matin; Swati Majumdar; Antonio M Vignola; Claus Kroegel; Ferran Morell; Trevor T Hansel; Stephen I Rennard; Christopher Compton; Ohad Amit; Tri Tat; Jeffrey Edelson; Ian D Pavord; Klaus F Rabe; Neil C Barnes; Peter K Jeffery
Journal: Am J Respir Crit Care Med Date: 2003-06-19 Impact factor: 21.405

2. Anti-inflammatory effects of salmeterol/fluticasone propionate 50/250 mcg combination therapy in Japanese patients with chronic obstructive pulmonary disease.

Authors: Kazuhisa Asai; Akihiro Kobayashi; Yukio Makihara; Malcolm Johnson
Journal: Int J Chron Obstruct Pulmon Dis Date: 2015-04-17

2 in total